Our Business Developer Jordan Palfrey is looking forward to attending the 3rd GPCR-Targeted Drug Discovery Summit in Boston from March 5-7, 2024. Please connect with Jordan if you’re interested in discovering GPCR therapeutic peptide hits using Orbit’s direct-to-cell high throughput functional screening capabilities. We’d be delighted to learn more and discuss how we can help!

< Back